GBIO vs WY · rev $19.9M vs P/E 43, rev $3.59B
Generation Bio Co (GBIO) versus Weyerhaeuser Company (WY) — a side-by-side from cached financials, not a winner call.
Generation Bio Co (GBIO) is a biotechnology company listed on US.
Weyerhaeuser Company (WY) is a reit - specialty company listed on NYSE.
Latest reported GBIO revenue for 2024-12-31 was $19.9M. Net income was -$131.7M. Revenue was up 236.9% from 2023-12-31 to 2024-12-31. GBIO currently screens at market cap $25.4M.
Latest reported WY revenue for 2026-06-30 was $3.59B. Net income was $318.0M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
GBIO currently screens at market cap $25.4M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
Not investment advice. Open the GBIO and WY stock pages for the full models.
Not investment advice.